Bayer CEO Says R&D Spending May Rise Next Year

Bayer CEO Says R&D Spending May Rise Next Year Play

Oct. 30 (Bloomberg) -- Marijn Dekkers, chief executive officer of Bayer AG, discusses the company's agreement to buy Schiff Nutrition International Inc., acquisition strategy and research investments. He speaks from Leverkusen, Germany, with Manus Cranny on Bloomberg Television's "The Pulse." (Source: Bloomberg)

blog comments powered by Disqus